PROK vs. ATRY.MC

Last updated Apr 2, 2026

Compare and contrast key facts about ProKidney Corp. (PROK) and Atrys Health, S.A. (ATRY.MC).

Performance

PROK vs. ATRY.MC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProKidney Corp. (PROK) and Atrys Health, S.A. (ATRY.MC). The values are adjusted to include any dividend payments, if applicable.

PROK vs. ATRY.MC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
PROK ProKidney Corp.	-21.87%	32.54%	-5.06%	-74.05%	-20.51%
ATRY.MC Atrys Health, S.A.	-0.94%	-1.38%	-13.85%	-38.94%	-4.47%

Different Trading Currencies

PROK is traded in USD, while ATRY.MC is traded in EUR. To make them comparable, the ATRY.MC values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, PROK achieves a -21.87% return, which is significantly lower than ATRY.MC's -0.94% return.

PROK

• 1D: -2.23%
• 1M: -24.24%
• YTD: -21.87%
• 6M: -32.69%
• 1Y: 110.84%
• 3Y*: -46.33%
• 5Y*: —
• 10Y*: —

ATRY.MC

• 1D: 2.81%
• 1M: 0.91%
• YTD: -0.94%
• 6M: 5.67%
• 1Y: 6.00%
• 3Y*: -16.18%
• 5Y*: -21.74%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PROK vs. ATRY.MC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PROK

PROK Risk / Return Rank: 75
PROK Sharpe Ratio Rank: 47
PROK Sortino Ratio Rank: 99
PROK Omega Ratio Rank: 98
PROK Calmar Ratio Rank: 69
PROK Martin Ratio Rank: 60

ATRY.MC

ATRY.MC Risk / Return Rank: 37
ATRY.MC Sharpe Ratio Rank: 38
ATRY.MC Sortino Ratio Rank: 34
ATRY.MC Omega Ratio Rank: 34
ATRY.MC Calmar Ratio Rank: 39
ATRY.MC Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PROK vs. ATRY.MC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProKidney Corp. (PROK) and Atrys Health, S.A. (ATRY.MC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PROK	ATRY.MC	Difference
Sharpe ratio Return per unit of total volatility	0.21	0.16	+0.05
Sortino ratio Return per unit of downside risk	6.16	0.56	+5.60
Omega ratio Gain probability vs. loss probability	1.70	1.06	+0.64
Calmar ratio Return relative to maximum drawdown	1.44	0.23	+1.21
Martin ratio Return relative to average drawdown	2.11	0.44	+1.68
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PROK vs. ATRY.MC - Sharpe Ratio Comparison

The current PROK Sharpe Ratio is 0.21, which is higher than the ATRY.MC Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of PROK and ATRY.MC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PROK	ATRY.MC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.21	0.16	+0.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.64	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	0.21	-0.33

Correlation

The correlation between PROK and ATRY.MC is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PROK vs. ATRY.MC - Dividend Comparison

Neither PROK nor ATRY.MC has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PROK vs. ATRY.MC - Drawdown Comparison

The maximum PROK drawdown since its inception was -96.29%, which is greater than ATRY.MC's maximum drawdown of -77.77%. Use the drawdown chart below to compare losses from any high point for PROK and ATRY.MC.

Drawdown Indicators

	PROK	ATRY.MC	Difference
Max Drawdown Largest peak-to-trough decline	-96.29%	-77.59%	-18.70%
Max Drawdown (1Y) Largest decline over 1 year	-69.11%	-25.07%	-44.04%
Max Drawdown (5Y) Largest decline over 5 years	—	-77.59%	—
Current Drawdown Current decline from peak	-87.30%	-73.75%	-13.55%
Average Drawdown Average peak-to-trough decline	-64.10%	-35.59%	-28.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	47.18%	13.85%	+33.33%

Volatility

PROK vs. ATRY.MC - Volatility Comparison

ProKidney Corp. (PROK) has a higher volatility of 24.90% compared to Atrys Health, S.A. (ATRY.MC) at 13.46%. This indicates that PROK's price experiences larger fluctuations and is considered to be riskier than ATRY.MC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PROK	ATRY.MC	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.90%	13.46%	+11.44%
Volatility (6M) Calculated over the trailing 6-month period	55.54%	27.47%	+28.07%
Volatility (1Y) Calculated over the trailing 1-year period	528.00%	37.91%	+490.09%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	290.99%	33.54%	+257.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	290.99%	42.08%	+248.91%

Financials